Makhoul M, Ayoub H, Awad S, Chemaitelly H, Abu-Raddad L
BMJ Public Health. 2025; 2(1):e000345.
PMID: 40018092
PMC: 11812766.
DOI: 10.1136/bmjph-2023-000345.
Li Y, Warren J, Poston T, Clutton G, Shaw F, Conrad S
J Infect Dis. 2024; 231(2):e385-e395.
PMID: 39250505
PMC: 11841636.
DOI: 10.1093/infdis/jiae443.
Andreacchio G, Longo Y, Moreno Mascaraque S, Anandasothy K, Tofan S, Ozun E
Vaccines (Basel). 2024; 12(8).
PMID: 39204067
PMC: 11360449.
DOI: 10.3390/vaccines12080944.
Roe S, Zhu T, Slepenkin A, Berges A, Fairman J, de la Maza L
Vaccines (Basel). 2024; 12(7).
PMID: 39066427
PMC: 11281497.
DOI: 10.3390/vaccines12070789.
Slepenkin A, Pal S, Rasley A, Coleman M, de la Maza L
NPJ Vaccines. 2024; 9(1):104.
PMID: 38858418
PMC: 11164897.
DOI: 10.1038/s41541-024-00880-6.
Antibody responses to vaccine candidate antigens in -infected women and correlation with antibody-mediated phagocytosis of elementary bodies.
Yu H, Geisler W, Dai C, Gupta K, Cutter G, Brunham R
Front Cell Infect Microbiol. 2024; 14:1342621.
PMID: 38371301
PMC: 10869445.
DOI: 10.3389/fcimb.2024.1342621.
Determination of the safety and efficacy of recombinant Chlamydia muridarum MOMP vaccines, formulated with CpG-1826 and 70%, 50%, 30% or 10% concentrations of Montanide ISA-720 VG, to elicit protective immune responses against a C. muridarum....
de la Maza L, Slepenkin A, Pal S, Rasley A, Coleman M
Res Sq. 2024; .
PMID: 38168233
PMC: 10760204.
DOI: 10.21203/rs.3.rs-3688658/v1.
Public willingness to receive chlamydia, gonorrhea, syphilis, and trichomoniasis vaccines: a scoping review.
Valleroy T, Garon C, Perroud J, Wagner A
BMC Health Serv Res. 2023; 23(1):1290.
PMID: 37996885
PMC: 10668406.
DOI: 10.1186/s12913-023-10334-9.
The Brazilian army and the low prevalence of sexually transmitted infections in women of the military garrison of Campinas between 2017 to 2020: a prospective, cross-sectional epidemiological study.
Lopes F, Tso F, de Gois Speck N
Sao Paulo Med J. 2023; 142(2):e2022557.
PMID: 37531524
PMC: 10393385.
DOI: 10.1590/1516-3180.2022.0557.R1.010623.
-An Emerging Old Entity?.
Grygiel-Gorniak B, Folga B
Microorganisms. 2023; 11(5).
PMID: 37317257
PMC: 10221348.
DOI: 10.3390/microorganisms11051283.
Natural Clearance of Chlamydia trachomatis Infection Is Associated With Distinct Differences in Cervicovaginal Metabolites.
Jordan S, Wilson L, Ren J, Gupta K, Barnes S, Geisler W
J Infect Dis. 2023; 228(8):1119-1126.
PMID: 37163744
PMC: 10582912.
DOI: 10.1093/infdis/jiad155.
Important considerations regarding the widespread use of doxycycline chemoprophylaxis against sexually transmitted infections.
Kong F, Kenyon C, Unemo M
J Antimicrob Chemother. 2023; 78(7):1561-1568.
PMID: 37129293
PMC: 10577522.
DOI: 10.1093/jac/dkad129.
Chitosan particle stabilized Pickering emulsion/interleukin-12 adjuvant system for Pgp3 subunit vaccine elicits immune protection against genital chlamydial infection in mice.
Shu M, Zhao L, Shi K, Lei W, Yang Y, Li Z
Front Immunol. 2022; 13:989620.
PMID: 36505424
PMC: 9727174.
DOI: 10.3389/fimmu.2022.989620.
Prevalence of , and in Asymptomatic Women from Urban-Peripheral and Rural Populations of Cuenca, Ecuador.
Abad S, Neira E, Vinansaca L, Escandon S, Neira V
Infect Dis Rep. 2022; 14(5):646-654.
PMID: 36136820
PMC: 9498753.
DOI: 10.3390/idr14050070.
as a Current Health Problem: Challenges and Opportunities.
Rodrigues R, Sousa C, Vale N
Diagnostics (Basel). 2022; 12(8).
PMID: 35892506
PMC: 9331119.
DOI: 10.3390/diagnostics12081795.
Combining Cellular Immunology With RNAseq to Identify Novel Chlamydia T-Cell Subset Signatures.
Johnson R, Asashima H, Mohanty S, Shaw A
J Infect Dis. 2022; 225(11):2033-2042.
PMID: 35172331
PMC: 9159333.
DOI: 10.1093/infdis/jiac051.
Induction of Protection in Mice against a Respiratory Challenge by a Vaccine Formulated with the Major Outer Membrane Protein in Nanolipoprotein Particles.
Tifrea D, He W, Pal S, Evans A, Gilmore S, Fischer N
Vaccines (Basel). 2021; 9(7).
PMID: 34358171
PMC: 8310061.
DOI: 10.3390/vaccines9070755.
A primary Chlamydia trachomatis genital infection of rhesus macaques identifies new immunodominant B-cell antigens.
Randall A, Teng A, Liang X, Pal S, Tarantal A, Fike J
PLoS One. 2021; 16(4):e0250317.
PMID: 33886668
PMC: 8061917.
DOI: 10.1371/journal.pone.0250317.
Vaccination with the recombinant major outer membrane protein elicits long-term protection in mice against vaginal shedding and infertility following a genital challenge.
Pal S, Cruz-Fisher M, Cheng C, Carmichael J, Tifrea D, Tatarenkova O
NPJ Vaccines. 2020; 5:90.
PMID: 33083025
PMC: 7530680.
DOI: 10.1038/s41541-020-00239-7.
Induction of protection in mice against a respiratory challenge by a vaccine formulated with exosomes isolated from infected cells.
Pal S, Mirzakhanyan Y, Gershon P, Tifrea D, de la Maza L
NPJ Vaccines. 2020; 5:87.
PMID: 33014435
PMC: 7501220.
DOI: 10.1038/s41541-020-00235-x.